JP2004515493A5 - - Google Patents

Download PDF

Info

Publication number
JP2004515493A5
JP2004515493A5 JP2002547901A JP2002547901A JP2004515493A5 JP 2004515493 A5 JP2004515493 A5 JP 2004515493A5 JP 2002547901 A JP2002547901 A JP 2002547901A JP 2002547901 A JP2002547901 A JP 2002547901A JP 2004515493 A5 JP2004515493 A5 JP 2004515493A5
Authority
JP
Japan
Prior art keywords
carbon atoms
alkyl
phenyl
hydrogen
carbons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002547901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004515493A (ja
JP4445198B2 (ja
Filing date
Publication date
Priority claimed from DE10060807A external-priority patent/DE10060807A1/de
Application filed filed Critical
Publication of JP2004515493A publication Critical patent/JP2004515493A/ja
Publication of JP2004515493A5 publication Critical patent/JP2004515493A5/ja
Application granted granted Critical
Publication of JP4445198B2 publication Critical patent/JP4445198B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002547901A 2000-12-07 2001-11-24 カリウムチャンネルインヒビターとして使用するためのオルソ置換含窒素ビスアリール化合物 Expired - Fee Related JP4445198B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10060807A DE10060807A1 (de) 2000-12-07 2000-12-07 Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
PCT/EP2001/013680 WO2002046162A1 (de) 2000-12-07 2001-11-24 Ortho-substituierte stickstoffhaltige bisarylverbindungen zur verwendung als kalium-kanal-inhibitoren

Publications (3)

Publication Number Publication Date
JP2004515493A JP2004515493A (ja) 2004-05-27
JP2004515493A5 true JP2004515493A5 (enExample) 2005-08-04
JP4445198B2 JP4445198B2 (ja) 2010-04-07

Family

ID=7666129

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002547901A Expired - Fee Related JP4445198B2 (ja) 2000-12-07 2001-11-24 カリウムチャンネルインヒビターとして使用するためのオルソ置換含窒素ビスアリール化合物

Country Status (30)

Country Link
US (1) US6794377B2 (enExample)
EP (1) EP1341764B1 (enExample)
JP (1) JP4445198B2 (enExample)
KR (1) KR100815070B1 (enExample)
CN (1) CN1237052C (enExample)
AR (1) AR033408A1 (enExample)
AT (1) ATE297897T1 (enExample)
AU (2) AU2189202A (enExample)
BR (1) BR0116005A (enExample)
CA (1) CA2436891C (enExample)
CZ (1) CZ301923B6 (enExample)
DE (2) DE10060807A1 (enExample)
DK (1) DK1341764T3 (enExample)
EE (1) EE05220B1 (enExample)
ES (1) ES2242792T3 (enExample)
HR (1) HRP20030448B1 (enExample)
HU (1) HUP0302762A3 (enExample)
IL (2) IL156312A0 (enExample)
MX (1) MXPA03004966A (enExample)
NO (1) NO325297B1 (enExample)
NZ (1) NZ526294A (enExample)
PL (1) PL207057B1 (enExample)
PT (1) PT1341764E (enExample)
RU (1) RU2275360C2 (enExample)
SI (1) SI1341764T1 (enExample)
SK (1) SK286056B6 (enExample)
TW (1) TWI242005B (enExample)
WO (1) WO2002046162A1 (enExample)
YU (1) YU40203A (enExample)
ZA (1) ZA200303931B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0124941D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124936D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124938D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124931D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124939D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
ATE485275T1 (de) * 2002-02-12 2010-11-15 Glaxosmithkline Llc Nicotinamide und deren verwendung als p38 inhibitoren
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
GB0308185D0 (en) * 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
US20050054673A1 (en) * 2003-09-08 2005-03-10 Aventis Pharma Deutschland Gmbh Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
DE10341233A1 (de) * 2003-09-08 2005-03-24 Aventis Pharma Deutschland Gmbh Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
GB0402143D0 (en) * 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
GB0412986D0 (en) 2004-06-10 2004-07-14 Xention Discovery Ltd Compounds
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
US20080051416A1 (en) * 2004-10-05 2008-02-28 Smithkline Beecham Corporation Novel Compounds
JP2008522978A (ja) * 2004-12-07 2008-07-03 エナンタ ファーマシューティカルズ インコーポレイテッド ３，６−ビシクロライド
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0512429D0 (en) * 2005-06-17 2005-07-27 Smithkline Beecham Corp Novel compound
AU2006276292B2 (en) * 2005-07-22 2010-09-16 Merck Sharp & Dohme Corp. Potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
NZ572231A (en) * 2006-04-27 2010-12-24 Sanofi Aventis Deutschland Inhibitors of the task-1 and task-3 ion channel
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
WO2011012592A1 (en) 2009-07-30 2011-02-03 F. Hoffmann-La Roche Ag Dihydropyrimidone amides as p2x7 modulators
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (enExample) 2011-07-01 2018-04-28
US20150045305A1 (en) 2012-01-27 2015-02-12 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
EP3263559A1 (en) * 2013-01-22 2018-01-03 Technische Universität Graz Lipase inhibitors
WO2014183221A1 (en) * 2013-05-17 2014-11-20 The Centre For Drug Research And Development Resveratrol analogs and therapeutic uses thereof
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
TW202246215A (zh) 2015-12-18 2022-12-01 美商亞德利克斯公司 作為非全身ｔｇｒ５促效劑之經取代之４－苯基吡啶化合物
JP7120549B2 (ja) 2016-12-15 2022-08-17 小野薬品工業株式会社 Ｔｒｅｋ（ｔｗｉｋ関連ｋチャネル）チャネルのアクチベータ
CN112074505B (zh) 2018-03-08 2024-04-05 因赛特公司 作为PI3K-γ抑制剂的氨基吡嗪二醇化合物
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4616002A (en) * 1984-11-09 1986-10-07 Ciba-Geigy Corporation Dihydro pyridine compounds, compositions and use
US5196537A (en) * 1991-03-21 1993-03-23 G. D. Searle & Co. 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
DE4430638A1 (de) * 1994-08-29 1996-03-07 Bayer Ag Verwendung von substituierten 4-Phenyl-6-amino-nicotinsäurederivaten als Arzneimittel
US5670504A (en) 1995-02-23 1997-09-23 Merck & Co. Inc. 2,6-diaryl pyridazinones with immunosuppressant activity
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US5935945A (en) 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US6333337B1 (en) * 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
EP1082315A1 (en) 1998-06-05 2001-03-14 Icagen, Inc. Potassium channel inhibitors
EP1109544A4 (en) * 1998-09-01 2004-10-27 Bristol Myers Squibb Co POTASSIUM CHANNEL INHIBITORS AND THEIR METHOD OF USE
DE19947457A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
DE10059418A1 (de) * 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Similar Documents

Publication Publication Date Title
JP2004515493A5 (enExample)
RU2003120080A (ru) Орто-замещенные азотсодержащие бисарильные соединения для применения в качестве ингибиторов калиевого канала, а также содержащие их фармацевтические композиции
RU2003119153A (ru) Орто-, мета-замещенные бис-арильные соединения, способ их получения, их применение в качестве медикаментов, а также содержащие их фармацевтические композиции
CA2436891A1 (en) Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
RU2003121236A (ru) Арилированные амиды фуран- и тиофенкарбоновых кислот с блокирующим калиевый канал действием
RU2002111561A (ru) 2'-замещенные 1,1'-бифенил-2-карбонамиды, способы их получения, их применение в качестве лекарственного средства, а также содержащие их фармацевтические композиции
ZA200303893B (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds.
JP2004533464A5 (enExample)
JP2003503385A5 (enExample)
JP4252798B2 (ja) カリウムチャネル遮断作用を有するアリール化フラン及びチオフェンカルボキサミド
RU2002101723A (ru) Инданилзамещенные бензолкарбонамиды, способ их получения, их применение в качестве лекарственного средства, а также содержащие их фармацевтические композиции
CA2694270A1 (en) Substituted aryloxazoles and the use thereof
JP2016518437A5 (enExample)
CA2445341A1 (en) Anthranilamides, process for their preparation, their use as antiarrhythmics, and pharmaceutical preparations thereof
JP2005538124A5 (enExample)
CA2134972C (en) Anti-ischemic medicament
CA2450076A1 (en) Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or a diagnostic agent and pharmaceutical preparations containing said compounds
JP2005534706A5 (enExample)
JPWO2023099623A5 (enExample)
JP2009533323A5 (enExample)
JP2004521150A5 (enExample)
JP2005526138A5 (enExample)
JP2024112835A5 (enExample)
JP2003513066A5 (enExample)
JP2008521934A5 (enExample)